NATALIE MOORE: Open Payments
NPI 1508574013 · SCHENECTADY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$816 in 24 payments from 9 companies in 2025. Trend: 2023 $600 · 2024 $466 · 2025 $816
Food & beverage: $744Education: $72
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 6 | $221 |
| Edwards Lifesciences Corporation | 2 | $207 |
| Amgen Inc. | 4 | $154 |
| Merck Sharp & Dohme LLC | 3 | $55 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $52 |
| Alnylam Pharmaceuticals Inc. | 2 | $38 |
| E.R. Squibb & Sons, L.L.C. | 2 | $34 |
| Actelion Pharmaceuticals US, Inc. | 1 | $31 |
| ABIOMED | 1 | $24 |
Products named: REPATHA, MICRA, JARDIANCE, ONPATTRO, VERQUVO, OPSYNVI, WINREVAIR, ELIQUIS.
Industry payments across NY — which companies pay providers there.
